<DOC>
	<DOCNO>NCT03067012</DOCNO>
	<brief_summary>The metabolic effect oncometabolic surgery ( long limb Roux-en Y reconstruction ) early gastric cancer patient reveal pilot study . However , nutritional safety deal previous literature . This prospective pilot study evaluate nutritional safety metabolic benefit oncometabolic surgery obese early gastric cancer patient .</brief_summary>
	<brief_title>Nutritional Safety Metabolic Benefits Oncometabolic Surgery Obese Gastric Cancer Patients</brief_title>
	<detailed_description>We perform long limb uncut Roux-en Y gastrojejunostomy ( uRYGJ ) 20 patient clinical T1N0 stage preoperative body mass index ( BMI ) ≥ 32.5 kg/m2 ≥ 27.5 kg/m2 co-morbidities September 2015 July 2016 . The primary endpoint incidence micronutrient ' deficiency ( iron , folate , vitamin B12 ) postoperative 1 year secondary endpoint anemia incidence , BMI change remission rate co-morbidities .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Metabolic Diseases</mesh_term>
	<criteria>Lesion locate distal mid stomach Lesion confine submucosa ( cT1b ) : Early gastric cancer No evidence metastatic enlarge lymph node Preoperative body mass index ( BMI ) ≥ 32.5 kg/m2 ≥ 27.5 kg/m2 comorbidities Being unable understand risk , benefit compliance requirement trial Non Korean speaker American society anesthesiology ( ASA ) class IV high Other malignancy within 5 year .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Oncometabolic surgery</keyword>
	<keyword>Long limb uncut Roux-en-Y gastrojejunostomy</keyword>
	<keyword>Obesity</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Early gastric cancer</keyword>
</DOC>